WIPRO Q2 FY27 Earnings Call: Guides -1.5% to 0.5% CC Growth, Two Large Deals Slip to Q3

Cofacto Research Published October 15, 2026 5 min read

WIPRO held its Q2 FY27 earnings call on October 15, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.

Modest Growth, Sequential Margin Uptick

IT services revenue of $2.61B — flat QoQ, +0.6% YoY in CC for Q2 FY 2026-2027, reflecting a stable demand environment with clients prioritizing efficiency and AI adoption.
Operating margin of 16.5% — up 0.5% QoQ in Q2 FY 2026-2027, though CFO Aparna Iyer noted margins were pressured by wage hikes (effective 1 March 2026) with operational improvements expected to aid recovery.
Net income of Rs.32B — down 5% sequentially in Q2 FY 2026-2027, impacted by lower other income from the June 2026 buyback; EPS improved 4.2% YoY to Rs.3.23.
Operating cash flow at 166% of net income — with gross cash at $4.6B in Q2 FY 2026-2027.
Q3 FY 2026-2027 revenue guidance of $2.571B–$2.625B — sequential CC growth of -1.5% to +0.5%, largely driven by seasonal furloughs and lower working days per CFO Aparna Iyer.

Q2 FY 2026-2027 TCV of $2.6B — with 9 large deals, including a consulting-led AI transformation deal for a global financial institution and an AI capability center for a mid-market consumer products company.
Two large deals slipped from Q2 FY 2026-2027 — management attributed the TCV decline to these delayed signings and expressed confidence in securing them, with an update expected in Q3 FY 2026-2027.
Delayed deals carry revenue upside into Q4 FY 2026-2027 — Srini Pallia cited confirmed orders from Q2 FY 2026-2027 held up by unsigned paperwork, now expected to close in Q3 FY 2026-2027.
Management expects several deals to close early in Q3 FY 2026-2027 — which should improve the revenue outlook for Q4 FY 2026-2027; the Q3 FY 2026-2027 pipeline was described as "very robust".
Four GCC opportunity areas outlined — greenfield, brownfield, and monetization models, with Wipro partnering with clients across all models.

AI strategy anchored on the Wipro intelligence stack — Build AI/Vega, Run AI/Wings, and Reimagine AI, per CEO Srini Pallia; the Reimagine AI unit spans AI consulting/advisory, new AI services, and an AI-native unit building industry-specific platforms (aviation, healthcare, telecom, mortgage, insurance).
AI-native unit (launched Q1 FY 2026-2027) has 2,000+ engineers — and delivered SLM deployments for a US retail bank, a Middle East petrochemical firm, and a US healthcare payer; management stated it is driving pipeline wins and marketplace success.
Five AI growth themes identified — AI data centers, AI foundry services, physical AI, devices, and design to manufacturing.
Tangible returns from strategic investments in FY 2026-2027 — including Mind Sprint and Harman DTS.
M&A kept open-ended — Srini Pallia declined to commit to the "big bang" scale proposed by analyst Sudhir Guntupalli, anchoring any future deal to the "consulting-led and AI-powered" strategy within priority sectors and markets; no numeric targets or capital-deployment timeline were committed.

BFSI grew 1% sequentially and 1.3% YoY in Q2 FY 2026-2027 — supported by a consulting-led transformation deal, a resuming mega deal ramp-up, improved momentum from a European captive client, and strong Capco performance across Americas, Continental Europe, and the UK.
Consumer grew 2.6% sequentially — while Tech & Comm declined 2.6% sequentially and Health declined 3.8% sequentially in Q2 FY 2026-2027.
Healthcare weakness attributed to US payer margin pressure and policy changes — Srini Pallia guided for seasonality benefit in Q3 FY 2026-2027, though muted vs. previous years; an 18% drop in health exchange enrollments in Q1 FY 2026-2027 was acknowledged as an impact, with new outsourcing opportunities emerging from cost pressures.
Geographic mix was divergent in Q2 FY 2026-2027 — Americas declined 4.7% YoY (grew 0.9% sequentially; Americas 1 down 2.1% sequentially), Europe grew 5.1% YoY, and APMEA grew 13% YoY.
BFSI and technology verticals expected to contest the growth lead in FY 2027-2028 — per management.

Headcount reduced by ~6,500 in Q2 FY 2026-2027 — management attributed the reduction to H1 seasonality (no campus hiring) and AI-driven productivity improvements, with campus hiring expected to resume in H2 FY 2027.
17-17.5% margin target band retained — but management declined to set a specific timeline for return (e.g., Q4 FY 2026-2027), citing continued investments in growth such as the AI-native unit.
Salary increase effective 1 March 2026 — CFO Aparna Iyer stated another increase is not under consideration.
Attrition remains a factor — management expressed hope for improvement without providing a specific figure.
Client-specific issues flagged in Q1 FY 2026-2027 largely behind — with residual impact expected to conclude by Q3 FY 2026-2027.

Q3 FY 2026-2027 furloughs guided broadly in line with Q3 FY 2025-2026 levels — per CFO Aparna Iyer, and baked into the guidance.
No full-year guidance for FY 2026-2027 provided — management cited sequential organic growth as an endeavor and deferred the outlook to the Q3 FY 2026-2027 earnings call.
Management cited an "extremely strong" pipeline — for Q3 FY 2026-2027, Q4 FY 2026-2027, and the year ahead (FY 2027-2028), with growth drivers including AI adoption, BFSI, Tech, and the energy segment in EMR.
Deflationary cycle seen maturing — CFO guided that the company is expected to reach an inflection curve "in a few quarters" (likely FY 2027-2028), given the average 2 to 2.5-year contract tenure and 1.5 to 2 years already spent in this phase.
Regional demand picture mixed — management noted the US economy is very strong with a robust pipeline, while Europe is focused on cost optimization, vendor consolidation, and sovereign AI strategies.